The biphasic NAD(P)H fluorescence response of astrocytes to dopamine reflects the metabolic actions of oxidative phosphorylation and glycolysis

Journal of Neurochemistry

Volumn 115, Issue 2, 2010, Pages 483-492

  Requardt, Robert P ^a   Wilhelm, Franziska ^a   Rillich, Jan ^a   Winkler, Ulrike ^a   Hirrlinger, Johannes ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

2 photon laser scanning microscopy; Dip; Dopamine; NAD(P)H fluorescence; Overshoot

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 1 RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLUORESCENCE; GLYCOLYSIS; LASER MICROSCOPY; MITOCHONDRIAL RESPIRATION; MOUSE; NEUROMODULATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; FLUORESCENCE; FORSKOLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GLYCOLYSIS; GREEN FLUORESCENT PROTEINS; LACTIC ACID; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; NAD; OXIDATIVE PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 78651265940     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06940.x     Document Type: Article

References (45)

1. Almeida A., Moncada S. and Bolanos J. P. (2004) Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo- 2-kinase pathway. Nat. Cell Biol. 6, 45-51.
2. Barros L. F. and Deitmer J. W. (2010) Glucose and lactate supply to the synapse. Brain Res. Rev. 63, 149-159.
3. Ben-Shachar D. (2002) Mitochondrial dysfunction in schizophrenia: A possible linkage to dopamine. J. Neurochem. 83, 1241-1251.
4. Berger F., Ramirez-Hernandez M. H. and Ziegler M. (2004) The new life of a centenarian: Signalling functions of NAD(P). Trends Biochem. Sci. 29, 111-118.
5. Bickler P. E., Fahlman C. S., Gray J. and McKleroy W. (2009) Inositol 1,4,5-triphosphate receptors and NAD(P)H mediate Ca2 + signaling required for hypoxic preconditioning of hippocampal neurons. Neuroscience 160, 51-60.
6. Cahoy J. D., Emery B., Kaushal A. et al. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function. J. Neurosci. 28, 264-278.
7. Dauer W. and Przedborski S. (2003) Parkinson's disease: Mechanisms and models. Neuron 39, 889-909.
8. Djouder N., Tuerk R. D., Suter M. et al. (2010) PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis. EMBO J. 29, 469-481.
9. Dringen R. and Hamprecht B. (1992) Glucose, insulin, and insulin-like growth factor I regulate the glycogen content of astroglia-rich primary cultures. J. Neurochem. 58, 511-517.
10. Dringen R., Gebhardt R. and Hamprecht B. (1993) Glycogen in astrocytes: Possible function as lactate supply for neighboring cells. Brain Res. 623, 208-214.
11. Duchen M. R. (1992) Ca2 + -dependent changes in the mitochondrial energetics in single dissociated mouse sensory neurons. Biochem. J. 283, 41-50.
12. Fiacco T. A. and McCarthy K. D. (2006) Astrocyte calcium elevations: Properties, propagation, and effects on brain signaling. Glia 54, 676-690.
13. Gandhi G. K., Cruz N. F., Ball K. K., Theus S. A. and Dienel G. A. (2009) Selective astrocytic gap junctional trafficking of molecules involved in the glycolytic pathway: Impact on cellular brain imaging. J. Neurochem. 110, 857-869.
14. Gassen M., Glinka Y., Pinchasi B. and Youdim M. B. (1996) Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction. Eur. J. Pharmacol. 308, 219-225.
15. Gu Q. (2002) Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity. Neuroscience 111, 815-835.
16. Hansson E. and Ronnback L. (1988) Neurons from substantia nigra increase the efficacy and potency of second messenger arising from striatal astroglia dopamine receptor. Glia 1, 393-397.
17. Hertz L., Peng L. and Dienel G. A. (2007) Energy metabolism in astrocytes: High rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J. Cereb. Blood Flow Metab. 27, 219-249.
18. Hirrlinger J. and Dringen R. (2010) The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking. Brain Res. Rev. 63, 177-188.
19. Hirrlinger J., Schulz J. B. and Dringen R. (2002) Effects of dopamine on the glutathione metabolism of cultured astroglial cells: Implications for Parkinson's disease. J. Neurochem. 82, 458-467.
20. Hurley R. L., Barre L. K., Wood S. D., Anderson K. A., Kemp B. E., Means A. R. and Witters L. A. (2006) Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J. Biol. Chem. 281, 36662-36672.
21. Hutchins D. A. and Rogers K. J. (1970) Physiological and drug-induced changes in the glycogen content of mouse brain. Br. J. Pharmacol. 39, 9-25.
22. Hutchinson D. S., Chernogubova E., Dallner O. S., Cannon B. and Bengtsson T. (2005) Beta-adrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1. Diabetologia 48, 2386-2395.
23. Kaplin A. I., Snyder S. H. and Linden D. J. (1996) Reduced nicotinamide adenine dinucleotide-selective stimulation of inositol 1,4,5- trisphosphate receptors mediates hypoxic mobilization of calcium. J. Neurosci. 16, 2002-2011.
24. Kasischke K. A., Vishwasrao H. D., Fisher P. J., Zipfel W. R. and Webb W. W. (2004) Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 305, 99-103.
25. Kimball S. R., Siegfried B. A. and Jefferson L. S. (2004) Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase. J. Biol. Chem. 279, 54103-54109.
26. Kondziella D., Brenner E., Eyjolfsson E. M. and Sonnewald U. (2007) How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia? Neurochem. Int. 50, 291-301.
27. Lovatt D., Sonnewald U., Waagepetersen H. S. et al. (2007) The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J. Neurosci. 27, 12255-12266.
28. Nolte C., Matyash M., Pivneva T., Schipke C. G., Ohlemeyer C., Hanisch U. K., Kirchhoff F. and Kettenmann H. (2001) GFAP promoter- controlled EGFP-expressing transgenic mice: A tool to visualize astrocytes and astrogliosis in living brain tissue. Glia 33, 72-86.
29. Okamura N. and Sakakibara R. (1998) A common phosphorylation site for cyclic AMP-dependent protein kinase and protein kinase C in human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Biosci. Biotechnol. Biochem. 62, 2039-2042.
30. Parihar M. S., Kunz E. A. and Brewer G. J. (2008) Age-related decreases in NAD(P)H and glutathione cause redox declines before ATP loss during glutamate treatment of hippocampal neurons. J. Neurosci. Res. 86, 2339-2352.
31. Pellerin L., Bouzier-Sore A. K., Aubert A., Serres S., Merle M., Costalat R. and Magistretti P. J. (2007) Activity-dependent regulation of energy metabolism by astrocytes: An update. Glia 55, 1251-1262.
32. Reuss B., Leung D. S., Ohlemeyer C., Kettenmann H. and Unsicker K. (2000) Regionally distinct regulation of astroglial neurotransmitter receptors by fibroblast growth factor-2. Mol. Cell. Neurosci. 16, 42-58.
33. Rider M. H., Bertrand L., Vertommen D., Michels P. A., Rousseau G. G. And Hue L. (2004) 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: Head-to-head with a bifunctional enzyme that controls glycolysis. Biochem. J. 381, 561-579.
34. Russell V. A., Oades R. D., Tannock R., Killeen P. R., Auerbach J. G., Johansen E. B. and Sagvolden T. (2006) Response variability in Attention-Deficit/Hyperactivity Disorder: A neuronal and glial energetics hypothesis. Behav. Brain Funct. 2, 30.
35. Schmidt M. and Dringen R. (2009) Differential effects of iodoacetamide and iodoacetate on glycolysis and glutathione metabolism of cultured astrocytes. Front Neuroenerg. 1, 1-10.
36. Seeman P. and Van Tol H. H. (1994) Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15, 264-270.
37. Shuttleworth C. W., Brennan A. M. and Connor J. A. (2003) NAD(P)H fluorescence imaging of postsynaptic neuronal activation in murine hippocampal slices. J. Neurosci. 23, 3196-3208.
38. Sorg O. and Magistretti P. J. (1991) Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes. Brain Res. 563, 227-233.
39. Tanaka S. (2006) Dopaminergic control of working memory and its relevance to schizophrenia: A circuit dynamics perspective. Neuroscience 139, 153-171.
40. Todd R. D. and Botteron K. N. (2001) Is attention-deficit/hyperactivity disorder an energy deficiency syndrome? Biol. Psychiatry 50, 151-158.
41. Uehara T., Sumiyoshi T., Itoh H. and Kurachi M. (2007) Dopamine D1 and D2 receptors regulate extracellular lactate and glucose concentrations in the nucleus accumbens. Brain Res. 1133, 193-199.
42. Verkhratsky A., Orkand R. K. and Kettenmann H. (1998) Glial calcium: Homeostasis and signaling function. Physiol. Rev. 78, 99-141.
43. Vishwasrao H. D., Heikal A. A., Kasischke K. A. and Webb W. W. (2005) Conformational dependence of intracellular NADH on metabolic state revealed by associated fluorescence anisotropy. J. Biol. Chem. 280, 25119-25126.
44. Ying W. (2008) NAD+/NADH and NADP+/NADPH in cellular functions and cell death: Regulation and biological consequences. Antioxid. Redox Signal. 10, 179-206.
45. Zarchin N., Meilin S., Rifkind J. and Mayevsky A. (2002) Effect of aging on brain energy-metabolism. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 132, 117-120.